InvestorLens

CVSA — COVISTA INC

Public company

Sign in to save3 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying CVSA?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
50
Institutional Conviction
Net distribution · 1 buying vs 1 selling last quarter
34
Macro Tailwind
Macro conditions are mixed for this sector
56
Why? — Evidence & Confidence ▾

Of 2 tracked investors who changed their CVSA position last quarter, 1 bought and 1 sold (50% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 56/100 in a Overheat regime).

Supporting evidence
  • +1 tracked investor added or increased positions last quarter (Ray Dalio)
  • +3 tracked investors reported holding CVSA at their latest filing
  • +Macro Health is 56/100 in a Overheat regime — historically acceptable for this sectorsource
Contradicting evidence — always shown
  • −1 tracked investor reduced or exited last quarter (0 reduced, 1 sold out)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.

About COVISTA INC (CVSA)

COVISTA INC (CVSA) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Ray Dalio (Bridgewater Associates), valued at $23M. Across recent filings, tracked investors recorded 8 new positions, 10 increased, 12 reduced, and 6 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in CVSA

50
/100
Mixed Activity
Added / Increased18
Reduced12
Exited6
BearishBullish
Crowded Trade Score™

How many top investors track CVSA

20
/100
Emerging Interest
3investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

CVSA Ownership Composition

How COVISTA INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Multi-Strategy / Quant
85% of tracked value
Institutions
3
tracked investors
Total Reported
$14.6M
combined 13F value
Types2
  • Multi-Strategy / Quant85.4%
  • Macro14.6%
Multi-Strategy / Quant(2)
85.4%
Macro(1)
14.6%

Tracked investors currently reporting CVSA

2 tracked investors have since exited this position — listed separately below.

  • Ray DalioJun 30, 2026
    Bridgewater Associates
    Shares
    17.2K
    Value
    $2.1M
    % Portfolio
    0.01%
  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    77.6K
    Value
    $9.7M
    % Portfolio
    0.00%
  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    22.5K
    Value
    $2.8M
    % Portfolio
    0.00%

Previously held CVSA

These investors reported CVSA in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Paul Tudor JonesTudor Investment Corp4.4K$675.6KSep 30, 2025
Steve CohenPoint72 Asset Management2.2K$253.6KMar 31, 2026

Recent activity

Frequently asked questions

How many institutional investors hold CVSA?
3 tracked institutional investors disclosed a position in CVSA (COVISTA INC) in their most recent 13F filing.
Who is the largest institutional holder of CVSA?
Ray Dalio, Bridgewater Associates, holds the largest disclosed position in CVSA, valued at $23M.
Did institutional ownership of CVSA increase or decrease?
Across recent 13F filings, tracked investors recorded 8 new positions, 10 increased, 12 reduced, and 6 fully exited CVSA.
Where does this CVSA ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.